Old drug, new hope? repurposed medication enters Parkinson's trial
NCT ID NCT05931575
Summary
This study is testing whether a drug called fasudil, already used for other conditions in Japan since 1995, is safe and can help control symptoms in people with early Parkinson's disease. It will involve 75 participants at up to 15 centers in Germany who will take the drug or a placebo for three weeks. The main goals are to check for side effects and see if it improves movement, daily activities, and quality of life for people with Parkinson's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON´S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Technische Universität München, Klinikum rechts der Isar, Klinik und Poliklinik für Neurologie
RECRUITINGMunich, 81675, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.